BRAF Mutation Diversity and Impact on Clinical Outcomes in Non-Small Cell Lung Cancer

被引：0

作者：

Lu, K. ^{[1
]}

Shen, J. P. ^{[2
]}

Lopez-Diaz, F. J. ^{[3
]}

Leal, A. ^{[4
]}

Woodward, B. D. ^{[1
]}

Velcheti, V. ^{[4
]}

Riess, J. W. ^{[5
]}

Mansfield, A. S. ^{[6
]}

Salgia, R. ^{[7
]}

Husain, H. ^{[1
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] CEPIMP Genom, Cordoba, Argentina

[4] NYU Langone, New York, NY USA

[5] Univ Calif Davis, Sacramento, CA USA

[6] Mayo Clin, Rochester, MN USA

[7] City Hope Natl Med Ctr, Duarte, CA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

BRAF; NSCLC; Targeted Therapy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.12C.01

引用

页码：S341 / S341

页数：1

共 50 条

[21] The incidence and clinical impact of bone metastases in non-small cell lung cancer [J].

Kuchuk, Michael ;

Kuchuk, Iryna ;

Sabri, Elham ;

Hutton, Brian ;

Clemons, Mark ;

Wheatley-Price, Paul .

LUNG CANCER, 2015, 89 (02) :197-202

[22] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer [J].

Marcin Nicoś ;

Paweł Krawczyk ;

Bożena Jarosz ;

Marek Sawicki ;

Justyna Szumiłło ;

Tomasz Trojanowski ;

Janusz Milanowski .

Clinical and Experimental Medicine, 2016, 16 :169-176

[23] BRAF AND PIK3CA GENE MUTATION STATUS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER [J].

Chen, Zhi-Hong ;

An, She-Juan ;

Xie, Zhi ;

Guo, Ai-Lin ;

Chen, Jian-Guang ;

Yan, Hong-Hong ;

Su, Jian ;

Chen, Zhi-Yong ;

Nang, Xu-Chao ;

Wu, Yi-Long .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S989-S990

[24] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer [J].

Nicos, Marcin ;

Krawczyk, Pawel ;

Jarosz, Bozena ;

Sawicki, Marek ;

Szumillo, Justyna ;

Trojanowski, Tomasz ;

Milanowski, Janusz .

CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (02) :169-176

[25] BRAF mutations in non-small cell lung cancer: has finally Janus opened the door? [J].

Caparica, Rafael ;

de Castro, Gilberto, Jr. ;

Gil-Bazo, Ignacio ;

Caglevic, Christian ;

Calogero, Raffaele ;

Giallombardo, Marco ;

Santos, Edgardo S. ;

Raez, Luis E. ;

Rolfo, Christian .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 :32-39

[26] Ongoing Progress in BRAF-Mutated Non-Small Cell Lung Cancer [J].

Abdayem, Pamela ;

Planchard, David .

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (11) :662-+

[27] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS [J].

Huang, Zhi-min ;

An, She J. ;

Wu, Yi-long .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) :S458-S458

[28] Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation [J].

Wu, Markus Y. ;

Zhang, Eric W. ;

Strickland, Matthew R. ;

Mendoza, Dexter P. ;

Lipkin, Lev ;

Lennerz, Jochen K. ;

Gainor, Justin F. ;

Heist, Rebecca S. ;

Digumarthy, Subba R. .

CANCERS, 2021, 13 (14)

[29] Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes [J].

Di Federico, Alessandro ;

De Giglio, Andrea ;

Gelsomino, Francesco ;

De Biase, Dario ;

Giunchi, Francesca ;

Palladini, Arianna ;

Sperandi, Francesca ;

Melotti, Barbara ;

Ardizzoni, Andrea .

CANCERS, 2022, 14 (14)

[30] Sorafenib in non-small cell lung cancer [J].

Zhang, Jianjun ;

Gold, Kathryn A. ;

Kim, Edward .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) :1417-1426

← 1 2 3 4 5 →